The current illness and treatment paradigm appears to be simple. You get sick, go to the doctor, and they treat you. It seems self-evident – how could it go otherwise?
It turns out that things can be different. And this whole paradigm, if it doesn’t collapse, will change greatly in the years to come.
This is the goal of Finnish startup Nightingale. They want to reform medicine as we know it.
And no, we aren’t talking about shamanism. “The medical system now is reactive,” says a company rep, “but the majority of disease, especially the most severe and chronic, is easier to prevent than to treat after-the-fact”.
The Finns developed a universal blood analysis that shows the likelihood of a patient having certain ailments in the future, and it casts a broad net. It ranges from diabetes to heart disease to dementia.
HOW DO WE CURE ILLNESS BEFORE IT HAPPENS?
“How many quarts of blood do you need for this analysis?” you may ask.
It’s just a little – about 5mL. That’s enough to analyze 220 biomarkers. With this, it’s possible to start preventative efforts LONG before the real problems begin.
“Is this a weekly thing?” you ask.
No. For optimal preventative analysis, it’s enough to draw blood 2-3 times a year.
Your next rejoinder is easy to foresee, but valid.
“I am immune to your sensationalist journalism and talk of the “next revolution”. None of us, including the author, will live to see it. This test will probably cost millions, anyway”.
It’s already in the works. They tested it nationwide in Finland last December. It’s also inexpensive (20 Euros) and will save the country a lot of money in the future.
“So when will we get it?”
The startup already entered the American market, and insurance companies showed interest. It reduces their costs and the cost of procedures for their clients. So it’ll be soon.
Photo by Unsplash